Literature DB >> 9796721

Gastroesophageal reflux disease versus Helicobacter pylori infection as the cause of gastric carditis.

Y Y Chen1, D A Antonioli, S J Spechler, J M Zeroogian, R K Goyal, H H Wang.   

Abstract

To explore the potential contributions of gastroesophageal reflux disease, as opposed to Helicobacter pylori infection, to the development of gastric carditis, we evaluated gastric carditis (using the criteria of the updated Sydney system for the classification of gastritis), clinical and morphologic features of esophagitis, and H. pylori infection (evaluation of Steiner stains) in biopsy specimens from the gastroesophageal squamocolumnar junction. We correlated clinical, endoscopic, and histologic features in an unselected group of 116 patients. Some degree of carditis was found in 107 (92%) of the patients. The mean age of the patients increased with increasing severity of carditis (P < .05). The various groups of patients with different degrees of carditis did not differ significantly in sex ratio, ethnic background, presence of obesity, percentage having symptoms of gastroesophageal reflux disease (such as heartburn, regurgitation, dysphagia, or odynophagia), endoscopic evidence of esophagitis and columnar epithelium in the distal esophagus, or histologic evidence of active esophagitis. The presence, however, of active gastritis and H. pylori infection in the distal stomach and/or in the cardia was significantly associated with carditis. In patients without carditis, H. pylori was not detected in any cardiac or distal gastric biopsy specimen. In contrast, H. pylori was demonstrated in gastric tissue samples (either from the cardia or distally) of patients with carditis, with the prevalence rate increasing with greater degrees of cardiac inflammation. The H. pylori prevalence rate was 12% in the group with mild carditis, 40% in those with moderate carditis, and 57% in patients with marked carditis (P = .0001). In summary, carditis is commonly found in patients with symptoms related to upper gastrointestinal diseases. From analysis of our study cohort, we concluded that carditis was significantly associated with H. pylori infection and active gastritis but not with symptoms or signs of gastroesophageal reflux disease. These findings suggest that carditis with histologic features similar to those of gastritis in the distal stomach was a sequel of H. pylori infection and represented a part of an H. pylori--associated gastric inflammation.

Entities:  

Mesh:

Year:  1998        PMID: 9796721

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  13 in total

Review 1.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  Does carditis have two different etiologies?

Authors:  C Wolf; C A Seldenrijk; R Timmer; R Breumelhof; A J Smout
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

3.  Foveolar hyperplasia at the gastric cardia: prevalence and associations.

Authors:  M Voutilainen; M Juhola; M Färkkilä; P Sipponen
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

4.  Effect of proton pump inhibitor therapy on inflammatory changes in the gastric cardia (carditis).

Authors:  Shailender Singh; Ajay Bansal; Srinivas Puli; Sachin Wani; Sharad Mathur; Amit Rastogi; Prateek Sharma
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

Review 5.  Gastric carditis: Is it a histological response to high concentrations of luminal nitric oxide?

Authors:  Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

6.  Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology.

Authors:  A Couvelard; J M Cauvin; D Goldfain; A Rotenberg; M Robaszkiewicz; J F Fléjou
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

7.  Bile reflux gastritis and intestinal metaplasia at the cardia.

Authors:  M F Dixon; N P Mapstone; P M Neville; P Moayyedi; A T R Axon
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 8.  Pathological issues of gastric and lower esophageal cancer: helicobacter pylori infection and its eradication.

Authors:  Takahiro Fujimori; Hitoshi Kawamata; Kazuhito Ichikawa; Yuko Ono; Yasuo Okura; Shigeki Tomita; Johji Imura
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

Review 9.  Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.

Authors:  Li-Dong Wang; Shu Zheng; Zuo-Yu Zheng; Alan G Casson
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

10.  Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.

Authors:  L J Williams; D L Guernsey; A G Casson
Journal:  Curr Oncol       Date:  2006-02       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.